Anemia and Heart Failure, An Issue of Heart Failure Clinics. Dieser Artikel ist nicht verfügbar.Anemia and Heart Failure, An Issue of Heart Failure Clinics

Anemia is common among patients with heart failure. The degree of anemia in patients with heart failure after acute myocardial infarction is associated with a poor prognosis, and anemia in patients with chronic heart failure from any cause has repeatedly been shown to predict a poor outcome. Heart failure specialists believe that correction of reduced hemoglobin should be studied further to see whether it can help in the management of this serious chronic disease. This issue brings together all of the most current information about the relationship of anemia to heart failure and the role of anemia treatment in management of heart failure.

Dr. Singh has led groundbreaking studies in anemia of kidney disease, including the CHOIR study, which was published in the New England Journal of Medicine, and well as being a member of the steering committees for the TREAT and DRIVE studies. More recently, he has taken on the role of leading the ASCEND Clinical development program - a phase 3 program for the development of a novel propyl hydroxylase inhibitor Daprodustat. The trial is aiming to recruit 7500 patients in over countries. He currently leads the office of Postgraduate Medical Education at the Brigham and Women's Hospital, and in this capacity leads several HMS CME courses. He is the author of over 160 original contributions and review articles, as well as author/editor of 11 books in internal medicine and nephrology. Dr. Singh is a Fellow of the Royal College of Physicians in London, and has an MBA from Boston University.